Pirfenidone increases IL-10 and improves acute pancreatitis in multiple clinically relevant murine models
Despite decades of research, there is no specific therapy for acute pancreatitis (AP). In the current study, we have evaluated the efficacy of pirfenidone, an antiinflammatory and antifibrotic agent that is approved by the FDA for treatment of idiopathic pulmonary fibrosis (IPF), in ameliorating loc...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Clinical investigation
2022-01-01
|
| Col·lecció: | JCI Insight |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1172/jci.insight.141108 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|